PL1678182T3 - Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn - Google Patents

Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Info

Publication number
PL1678182T3
PL1678182T3 PL04796445T PL04796445T PL1678182T3 PL 1678182 T3 PL1678182 T3 PL 1678182T3 PL 04796445 T PL04796445 T PL 04796445T PL 04796445 T PL04796445 T PL 04796445T PL 1678182 T3 PL1678182 T3 PL 1678182T3
Authority
PL
Poland
Prior art keywords
triazolo
pyrazolo
pyrimidines
amino
preparing substituted
Prior art date
Application number
PL04796445T
Other languages
English (en)
Inventor
Shen-Chun Kuo
David Jieh-Shyh Tsai
Loc Thanh Tran
Pengyi Zhang
Andrew D Jones
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL1678182T3 publication Critical patent/PL1678182T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL04796445T 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn PL1678182T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28
PCT/US2004/035472 WO2005044819A1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
EP04796445A EP1678182B1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines

Publications (1)

Publication Number Publication Date
PL1678182T3 true PL1678182T3 (pl) 2007-05-31

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04796445T PL1678182T3 (pl) 2003-10-28 2004-10-26 Sposób wytwarzania podstawionych 5-aminopirazolo[4,3-e]-1,2,4-triazolo-[1,5-c]pirymidyn

Country Status (18)

Country Link
US (4) US7223861B2 (pl)
EP (1) EP1678182B1 (pl)
JP (2) JP4782693B2 (pl)
CN (2) CN1898246B (pl)
AR (1) AR046560A1 (pl)
AT (1) ATE353331T1 (pl)
CA (1) CA2543431A1 (pl)
CY (1) CY1106393T1 (pl)
DE (1) DE602004004677T2 (pl)
DK (1) DK1678182T3 (pl)
ES (1) ES2278353T3 (pl)
HR (1) HRP20070063T3 (pl)
MX (1) MXPA06004722A (pl)
PL (1) PL1678182T3 (pl)
PT (1) PT1678182E (pl)
SI (1) SI1678182T1 (pl)
WO (1) WO2005044819A1 (pl)
ZA (1) ZA200603307B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1283839T1 (pl) * 2000-05-26 2005-08-31 Schering Corp
PT1678182E (pt) * 2003-10-28 2007-04-30 Schering Corp Processo para preparar 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pirimidinas
EP1902716A4 (en) * 2005-06-07 2009-05-13 Kyowa Hakko Kirin Co Ltd PROPHYLACTIC AND / OR THERAPEUTIC AGENT FOR MOTOR TROUBLESHOOTING
EP2462144B1 (en) 2009-08-07 2017-09-20 Merck Sharp & Dohme Corp. PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
WO2013168196A1 (ja) 2012-05-10 2013-11-14 ユニテクノ株式会社 半導体搬送テスト治具
SG10201806450SA (en) * 2014-09-26 2018-09-27 Hoffmann La Roche PROCESSES FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS
WO2020106560A1 (en) 2018-11-20 2020-05-28 Merck Sharp & Dohme Corp. Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
WO2020106558A1 (en) 2018-11-20 2020-05-28 Merck Sharp & Dohme Corp. Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
CR20210271A (es) 2018-11-30 2021-07-14 Merck Sharp & Dohme Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso
JP2022511778A (ja) 2018-11-30 2022-02-01 メルク・シャープ・アンド・ドーム・コーポレーション アデノシン受容体拮抗薬としての7-、8-及び10-置換されたアミノトリアゾロキナゾリン誘導体、医薬組成物及びそれらの使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
SI1283839T1 (pl) 2000-05-26 2005-08-31 Schering Corp
CN1491227A (zh) 2001-02-05 2004-04-21 株式会社大V制药工厂 三唑并喹唑啉和吡唑并三唑并嘧啶衍生物、医药组合物、腺苷 a 3受体亲和剂、降眼压剂、预防和治疗青光眼的制剂及降低眼压的方法
MXPA03010002A (es) * 2001-05-01 2004-06-30 Fujisawa Pharmaceutical Co Compuestos de cefemo.
US6916811B2 (en) * 2001-11-30 2005-07-12 Schering Corporation Adenosine A2a receptor antagonists
PT1678182E (pt) * 2003-10-28 2007-04-30 Schering Corp Processo para preparar 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pirimidinas
JP2007513091A (ja) * 2003-12-01 2007-05-24 シェーリング コーポレイション 置換された5−アミノ−ピラゾロ−[4,3−e]−1,2,4−トリアゾロ[1,5−c]ピリミジンを調製するための方法

Also Published As

Publication number Publication date
CY1106393T1 (el) 2011-10-12
CN101899050A (zh) 2010-12-01
US7601833B2 (en) 2009-10-13
DK1678182T3 (da) 2007-06-04
ES2278353T3 (es) 2007-08-01
US20050090492A1 (en) 2005-04-28
US20090326241A1 (en) 2009-12-31
CN1898246A (zh) 2007-01-17
SI1678182T1 (sl) 2007-06-30
DE602004004677D1 (de) 2007-03-22
HRP20070063T3 (hr) 2007-04-30
EP1678182A1 (en) 2006-07-12
WO2005044819A1 (en) 2005-05-19
ATE353331T1 (de) 2007-02-15
US7223861B2 (en) 2007-05-29
US20090005559A1 (en) 2009-01-01
PT1678182E (pt) 2007-04-30
JP4782693B2 (ja) 2011-09-28
JP2007509948A (ja) 2007-04-19
ZA200603307B (en) 2008-07-30
CN1898246B (zh) 2010-10-27
DE602004004677T2 (de) 2007-11-15
JP2011116795A (ja) 2011-06-16
MXPA06004722A (es) 2006-07-05
EP1678182B1 (en) 2007-02-07
US7439361B2 (en) 2008-10-21
US20070203340A1 (en) 2007-08-30
HK1086008A1 (en) 2006-09-08
AR046560A1 (es) 2005-12-14
CA2543431A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
IL182177A0 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
TWI365189B (en) Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives
EP1599482A4 (en) PYRAZOLO1,5-A PYRIMIDINE DERIVATIVES
ZA200702541B (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c]pyrid-2-ones
IL160878A0 (en) Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
SG133602A1 (en) Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
PL379009A1 (pl) Pochodne pirazolo [1,5-a] [1,3,5] triazyny jako ligandy receptora kanabinoidowego
EP1653969A4 (en) PYRROLO 1,2-B PYRIDAZINE DERIVATIVES
IL220174A0 (en) 5-AMINO - {PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE}-2-AND 7-SUBSTITUTED DERIVATIVES AS ADENOSINE A2A RECEPTOR INHIBITORS
IL170680A0 (en) 8 - SUBSTITUTED - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-a] PYRIMIDIN - 4 - ONE DERIVATIVES
IL178674A0 (en) PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS
ZA200604960B (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-A]pyrimidin-6-onederivatives
IL186422A0 (en) Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
ZA200507192B (en) Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido [1,2-A] pyrimidin-4-one derivatives
PT1622912E (pt) Antagonistas 2-alcinil- e 2-alcenilpirazolo-[4,3-b]-1,2,4- triazolo-[1,5-c]-pirimidina do receptor a2a da adenosina
SI1678182T1 (sl) Postopek priprave substituiranih 5-amino-pirazolo- (4,3-e)-1,2,4-triazolo(1,5-)pirimidinov
WO2005054245A3 (en) Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
PL370565A1 (pl) Pochodne 5-metoksy-8-arylo[1,2,4]triazolo[1,5-a]pirydyny
IL175753A0 (en) PROCESSES FOR THE PREPARATION OF PYRAZOLO [1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF
GB2424883B (en) Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
IL176471A0 (en) Process for the preparation of triazolopyrimidines
AU2003248987A8 (en) Process for preparing 7-azaindoles
ZA200600471B (en) 7-substituted 3-nitro-pyrazolo[1,5-A] pyrimidines
IL189370A0 (en) PROCESS FOR PRODUCING IMIDAZO[1,2-b]PYRIDAZINE COMPOUND